Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide Survey

Auriacombe, 2004, French field experience with buprenorphine, Am. J. Addict., 13, S17, 10.1080/10550490490440780 Auriacombe, 2001, Deaths attributable to methadone vs buprenorphine in France, JAMA, 285, 45, 10.1001/jama.285.1.45 Bick, 2007, HIV and Viral Hepatitis in Corrections: A Public Health Opportunity Binswanger, 2007, Release from prison—a high risk of death for former inmates, N. Engl. J. Med., 356, 157, 10.1056/NEJMsa064115 Bird, 2003, Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996–99, Addiction, 98, 185, 10.1046/j.1360-0443.2003.00264.x Carrieri, 2006, Buprenorphine use: the international experience, Clin. Infect. Dis., 43, S197, 10.1086/508184 CDC, 2002. Substance abuse treatment for injecting drug users: a strategy with many benefits. Centers for Disease Control and Prevention, Atlanta. CEC, 2007. Report from the Commission to the European Parliament and the Council on the implementation of the Council Recommendation of 18 June 2003 on the prevention and reduction of health-related harm associated with drug dependence. Commission of the European Communities. Clarke, 2001, Active and former injection drug users report of HIV risk behaviors during periods of incarceration, Subst. Abus., 22, 209, 10.1080/08897070109511463 Comer, 2002, Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers, J. Pharmacol. Exp. Ther., 303, 695, 10.1124/jpet.102.038141 Dolan, 2005, Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection, Addiction, 100, 820, 10.1111/j.1360-0443.2005.01050.x Dole, 1969, Methadone treatment of randomly selected criminal addicts, N. Engl. J. Med., 280, 1372, 10.1056/NEJM196906192802502 Drucker, 1999, Drug prohibition and public health: 25 years of evidence, Public Health Rep., 114, 14, 10.1093/phr/114.1.14 Fallon, 2001, The Key Extended Entry Program (KEEP): from the community side of the bridge, Mt. Sinai J. Med., 68, 21 Fhima, 2001, Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex), Ann. Med. Interne. (Paris), 152, IS26 Fiellin, 2002, Clinical practice. Office-based treatment of opioid-dependent patients, N. Engl. J. Med., 347, 817, 10.1056/NEJMcp013579 Freudenberg, 2001, Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health, J. Urban Health, 78, 214, 10.1093/jurban/78.2.214 Gerra, 2003, Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables, J. Subst. Abuse Treat., 25, 1, 10.1016/S0740-5472(03)00031-X Gordon, 2008, A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release, Addiction, 103, 1333, 10.1111/j.1360-0443.2008.002238.x Gore, 1995, Drug injection and HIV prevalence in inmates of Glenochil prison, BMJ, 310, 293, 10.1136/bmj.310.6975.293 Greifinger, 2007, Thirty Years Since Estelle v. Gamble Hammett, 2006, HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response, Am. J. Public Health, 96, 974, 10.2105/AJPH.2005.066993 Hanlon, 1990, Trends in criminal activity and drug use over an addiction career, Am. J. Drug Alcohol Abuse, 16, 223, 10.3109/00952999009001585 Heimer, 2006, Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico, Drug Alcohol Depend., 83, 122, 10.1016/j.drugalcdep.2005.11.004 Inciardi, 1998, Editors’ introduction: HIV/AIDS interventions for out-of-treatment drug users, J. Psychoactive Drugs, 30, 225, 10.1080/02791072.1998.10399696 Kakko, 2003, 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial, Lancet, 361, 662, 10.1016/S0140-6736(03)12600-1 Kang, 2005, HIV transmission behaviors in jail/prison among Puerto Rican drug injectors in New York and Puerto Rico, AIDS Behav., 9, 377, 10.1007/s10461-005-9011-4 Kinlock, 2002, A novel opioid maintenance program for prisoners: preliminary findings, J. Subst. Abuse Treat., 22, 141, 10.1016/S0740-5472(02)00226-X Kinlock, 2008, A study of methadone maintenance for male prisoners: 3 month post-release outcomes, Crim. Justice Behav., 35, 34, 10.1177/0093854807309111 Kinlock, 2008, A study of methadone maintenance for male prisoners: 3-month postrelease outcomes, Crim. Justice Behav., 35, 34, 10.1177/0093854807309111 Krebs, 2002, Intraprison HIV transmission: an assessment of whether it occurs, how it occurs, and who is at risk, AIDS Educ. Prev., 14, 53, 10.1521/aeap.14.7.53.23865 Kreek, 1992, Rationale for maintenance pharmacotherapy of opiate dependence, Res. Publ. Assoc. Res. Nerv. Ment. Dis., 70, 205 Kreek, 2000, Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine, Ann. N Y Acad. Sci., 909, 186, 10.1111/j.1749-6632.2000.tb06683.x Krinsky, 2009, Drugs, detention, and death: a study of the mortality of recently released prisoners, Am. J. Forensic Med. Pathol., 30, 6, 10.1097/PAF.0b013e3181873784 Lipton, 1992, Correctional drug abuse treatment in the United States: an overview Marsch, 1998, The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis, Addiction, 93, 515, 10.1046/j.1360-0443.1998.9345157.x Martin, 1999, Three year outcomes of therapeutic community treatment for drug-involved offenders in Delaware: From prison to work release to aftercare, The Prison J., 79 McKenzie, 2005, Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program, J. Opioid Manage., 1, 147, 10.5055/jom.2005.0034 McLellan, 1993, The effects of psychosocial services in substance abuse treatment, JAMA, 269, 1953, 10.1001/jama.269.15.1953 Møller, 2007 Mumola, 2006 Nurco, 1991, Recent research on the relationship between illicit drug use and crime, Behav. Sci. Law, 9, 221, 10.1002/bsl.2370090303 Rich, 2005, Attitudes and practices regarding the use of methadone in US state and federal prisons, J. Urban Health, 82, 411, 10.1093/jurban/jti072 Rich, 2005, Linkage with methadone treatment upon release from incarceration: a promising opportunity, J. Addict. Dis., 24, 49, 10.1300/J069v24n03_04 Sabol, W., Couture, H., 2008. Prison Inmates at Midyear 2007. US Department of Justice. SAMHSA, 2007. National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Washington DC. Seal, 2008, Substance use and sexual behavior during incarceration among 18- to 29-year old men: prevalence and correlates, AIDS Behav., 12, 27, 10.1007/s10461-007-9217-8 Springer, 2007 Visher, 2007, Reentry experiences of men with health problems Walmsley, R., 2008. World Prison Population List. Kings College of London International Centre for Prison Studies, London. WHO, 2005. WHO Status Paper on Prisons, Drugs and Harm Reduction. WHO, 2007